Non-Hodgkin lymphoma screening: Difference between revisions
Jump to navigation
Jump to search
Preeti Singh (talk | contribs) No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{CMG}}; {{AE}} | __NOTOC__ | ||
{{Non-Hodgkin lymphoma}} | |||
{{CMG}}; {{AE}} | |||
==Overview== | ==Overview== | ||
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for Non-Hodgkin lymphoma. | According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for Non-Hodgkin lymphoma. |
Revision as of 17:01, 28 December 2018
Non-Hodgkin lymphoma Microchapters |
Differentiating Non-Hodgkin's Lymphoma |
---|
Treatment |
Case Studies |
Non-Hodgkin lymphoma screening On the Web |
American Roentgen Ray Society Images of Non-Hodgkin lymphoma screening |
Risk calculators and risk factors for Non-Hodgkin lymphoma screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for Non-Hodgkin lymphoma.
Screening
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for Non-Hodgkin lymphoma.